| Role |
Name |
Disclosure |
Details |
| Author | John Boone, MD, Consulting Staff, Department of Otolaryngology, Naval Hospital Oak Harbor | Nothing to disclose | Details | | Coauthor | Charles S Kuzma, MD, Consulting Staff, Cancer Care Associates | Nothing to disclose | Details | | Medical Editor | Karen Seiter, MD, Professor, Department of Internal Medicine, Division of Oncology/Hematology, New York Medical College | Novartis Celgene Schering | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Lawrence H Brent, MD, Associate Professor of Medicine, Thomas Jefferson University; Chair, Program Director, Department of Medicine, Division of Rheumatology, Albert Einstein Medical Center | Genentech Genentch Genentech Abbott Immunology Amgen Wyeth | Details | | CME Editor | Rajalaxmi McKenna, MD, FACP, Consulting Staff, Department of Medicine, Southwest Medical Consultants, SC, Good Samaritan Hospital, Advocate Health Systems | Nothing to disclose | Details | | Chief Editor | Emmanuel C Besa, MD, Professor, Department of Medicine, Division of Hematologic Malignancies, Kimmel Cancer Center, Thomas Jefferson University | Nothing to disclose | Details |
|